These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14234010)

  • 1. THE DURATION OF THE MYELOTOXIC EFFECTS OF CIRCULATING ALKYLATING AGENTS.
    ULFOHN A; KRAMER SP; DORFMAN H; WITTEN B; WILLIAMSON C; SASS S; MILLER JI; SELIGMAN AM
    Cancer Res; 1964 Oct; 24():1659-65. PubMed ID: 14234010
    [No Abstract]   [Full Text] [Related]  

  • 2. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
    GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
    J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
    [No Abstract]   [Full Text] [Related]  

  • 3. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme-alterable alkylating agents. IV. Treatment of cancer in children with repetitive massive doses of S-46, protecting the extremity marrow by tourniquets.
    SCHILLING A
    Cancer; 1963 Jun; 16():727-36. PubMed ID: 13991706
    [No Abstract]   [Full Text] [Related]  

  • 5. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. II. MECHANISM OF PROTECTION.
    CALCUTT G; CONNORS TA; ELSON LA; ROSS WC
    Biochem Pharmacol; 1963 Aug; 12():833-7. PubMed ID: 14071540
    [No Abstract]   [Full Text] [Related]  

  • 6. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRE-TREATMENT. IV. PROTECTION AGAINST BONE MARROW DAMAGE.
    CONNORS TA; DOUBLE JA; ELSON LA; JENEY A
    Biochem Pharmacol; 1965 Apr; 14():569-77. PubMed ID: 14330623
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECT OF CERTAIN ANTITUMOR DRUGS ON REGENERATION IN RABBITS.
    SAMOILOV NN
    Fed Proc Transl Suppl; 1964; 23():37-8. PubMed ID: 14112002
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective use of a new alkylating agent in doses lethal to bone marrow with protection by tourniquets of marrow in the extremis.
    GOODMAN LE; SCHILLING A; KRAMER SP; ULFOHN A; MILLER S; KRAVITZ S; GABY SD; BAKAL D; WITTEN B; SELIGMAN AM
    Surg Forum; 1961; 12():130-2. PubMed ID: 13900321
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON THE POSSIBILITY OF PROLONGING THE VIABILITY OF SKIN TRANSPLANTS IN RABBITS WITH ALKYLATING SUBSTANCES].
    POPOV VI; NEZDATNYI MM
    Patol Fiziol Eksp Ter; 1964; 8():37-9. PubMed ID: 14184390
    [No Abstract]   [Full Text] [Related]  

  • 10. [CHANGES IN THE AMOUNT OF SULFHYDRYL COMPOUNDS IN THE BLOOD SERUM AND TISSUES OF TRANSPLANTED RAT TUMORS UNDER THE INFLUENCE OF ANTINEOPLASTIC ALKYLATING PREPARATIONS].
    KULIK GI
    Vopr Onkol; 1964; 10():70-4. PubMed ID: 14259823
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective use of a new alkylating agent in children with protection by tourniquets of marrow in the extremities.
    SELIGMAN AM
    Sinai Hosp J (Balt); 1961; 10():91-4. PubMed ID: 13910424
    [No Abstract]   [Full Text] [Related]  

  • 12. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 13. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 14. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE INFLUENCE ON CARBOHYDRATE METABOLISM OF TUMORS OF CHOMOTHERAPEUTIC DRUGS].
    KROEGER H
    Z Naturwiss Med Grundlagenforsch; 1963 Apr; 1():126-42. PubMed ID: 14159165
    [No Abstract]   [Full Text] [Related]  

  • 16. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.
    SANDERSON RP; MCKENNA JM; BLAKEMORE WS
    Nature; 1965 Jan; 205():479-81. PubMed ID: 14265292
    [No Abstract]   [Full Text] [Related]  

  • 17. [BEHAVIOR OF HEMATIC CRASIS IN PATIENTS AFFECTED BY GENITAL NEOPLASMS, SUBJECTED TO CHEMOTHERAPY WITH A NEW DERIVATIVE OF SARCOLYSIN].
    VARIATI G
    Ann Ostet Ginecol; 1964 Jun; 86():487-95. PubMed ID: 14203763
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTITUMOR EFFECT OF OLIVOMYCIN COMBINED WITH VARIOUS SYNTHETIC CYTOTOXIC DRUGS.
    ROSSOLIMO OK; LEPESHKINA GN
    Fed Proc Transl Suppl; 1964; 23():484-6. PubMed ID: 14185884
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECT OF ALKYLATING AGENTS AND WHOLE-BODY X-IRRADIATION ON THYMUS.
    HERRANEN A
    Nature; 1964 Aug; 203():891-2. PubMed ID: 14204093
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH.
    CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T
    Neoplasma; 1964; 11():137-44. PubMed ID: 14160693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.